THEMISMED — Themis Medicare Share Price
- IN₹25.41bn
- IN₹25.99bn
- IN₹3.82bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 6.17 | ||
Price to Tang. Book | 6.17 | ||
Price to Free Cashflow | 135.51 | ||
Price to Sales | 6.04 | ||
EV to EBITDA | 40.83 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.86% | ||
Return on Equity | 13.65% | ||
Operating Margin | 12.53% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 2,015.88 | 2,306.7 | 3,946.14 | 3,543.23 | 3,817.61 | n/a | n/a | 15.75% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | +44.02 | +103.55 | -21.93 | -23.53 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.
Directors
- Hoshang Sinor NEC (76)
- Sachin Patel CEO (46)
- Dinesh Patel VCH (73)
- Tushar Dalal CFO
- Sangameshwar Lyer CCO
- Jayshree Patel EDR (66)
- Luis Dias OTH
- Shashikant Kurani OTH
- T. Damodar Reddy OTH
- Gabar Gulacsi DRC
- Hariharan Subramaniam DRC
- Rajneesh Anand NED (60)
- Lajos Kovacs NED (52)
- Bhasker Iyer IND (65)
- Manjul Sandhu IND
- Vijay Agarwal NID (62)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- May 31st, 1969
- Public Since
- April 2nd, 2007
- No. of Shareholders
- 11,517
- No. of Employees
- 1,541
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 92,040,120
- Address
- 11/12 Udyog Nagar, MUMBAI, 400104
- Web
- https://www.themismedicare.com/
- Phone
- +91 2267607080
- Auditors
- Krishaan & Co.
Upcoming Events for THEMISMED
Similar to THEMISMED
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 22:42 UTC, shares in Themis Medicare are trading at IN₹276.05. This share price information is delayed by 15 minutes.
Shares in Themis Medicare last closed at IN₹276.05 and the price had moved by +65.95% over the past 365 days. In terms of relative price strength the Themis Medicare share price has outperformed the S&P BSE 100 Index by +30.73% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Themis Medicare dividend yield is 0.18% based on the trailing twelve month period.
Last year, Themis Medicare paid a total dividend of IN₹0.50, and it currently has a trailing dividend yield of 0.18%. We do not have any data on when Themis Medicare is to next pay dividends.
We do not have data on when Themis Medicare is to next pay dividends. The historic dividend yield on Themis Medicare shares is currently 0.18%.
To buy shares in Themis Medicare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹276.05, shares in Themis Medicare had a market capitalisation of IN₹25.41bn.
Here are the trading details for Themis Medicare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: THEMISMED
Based on an overall assessment of its quality, value and momentum Themis Medicare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Themis Medicare. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +24.54%.
As of the last closing price of IN₹276.05, shares in Themis Medicare were trading +16.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Themis Medicare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹276.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Themis Medicare's management team is headed by:
- Hoshang Sinor - NEC
- Sachin Patel - CEO
- Dinesh Patel - VCH
- Tushar Dalal - CFO
- Sangameshwar Lyer - CCO
- Jayshree Patel - EDR
- Luis Dias - OTH
- Shashikant Kurani - OTH
- T. Damodar Reddy - OTH
- Gabar Gulacsi - DRC
- Hariharan Subramaniam - DRC
- Rajneesh Anand - NED
- Lajos Kovacs - NED
- Bhasker Iyer - IND
- Manjul Sandhu - IND
- Vijay Agarwal - NID